Izzar Rachid, Head of Global Product Strategy, sold Biogen Inc. ($BIIB) shares on the open market once in the last year for a total of $300 thousand. His most recent sale occurred on July 8, 2025. Among 11,678 insiders, his sales rank 7,556th by amount, well below the average of 8.6 million per seller across 6.4 transactions. He made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | A | Restricted Stock Unit | 7390 | $0.00 | 7,390.0000 | 170,500,000 | 9999.99% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 3043 | $0.00 | 11,786.0000 | 170,500,000 | 34.80% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 458 | $201.18 | 8,743.0000 | 170,500,000 | 4.98% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 1802 | $0.00 | 9,201.0000 | 170,500,000 | 24.35% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 805 | $201.18 | 7,399.0000 | 170,500,000 | 9.81% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 2044 | $0.00 | 8,204.0000 | 170,500,000 | 33.18% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 775 | $201.18 | 11,011.0000 | 170,500,000 | 6.58% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 3043 | $0.00 | 6,087.0000 | 170,500,000 | 33.33% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 1802 | $0.00 | 1,802.0000 | 170,500,000 | 50.00% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 2044 | $0.00 | 0.0000 | 170,500,000 | 100.00% | 0.00% |
| July 8, 2025 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | S | Common Stock | 2223 | $135.00 | 6,330.0000 | 170,400,000 | 25.99% | 0.00% |
| Feb. 10, 2025 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 1515 | $0.00 | 0.0000 | 169,500,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 1515 | $0.00 | 8,998.0000 | 169,500,000 | 20.25% | 0.00% |
| Feb. 10, 2025 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 445 | $142.54 | 8,553.0000 | 169,500,000 | 4.95% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 565 | $141.35 | 6,059.0000 | 169,500,000 | 8.53% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 2043 | $0.00 | 7,224.0000 | 169,500,000 | 39.43% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 600 | $141.35 | 6,624.0000 | 169,500,000 | 8.31% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 1801 | $0.00 | 7,860.0000 | 169,500,000 | 29.72% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 2043 | $0.00 | 2,044.0000 | 169,500,000 | 49.99% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 1801 | $0.00 | 3,604.0000 | 169,500,000 | 33.32% | 0.00% |
| Feb. 6, 2025 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | A | Restricted Stock Unit | 9130 | $0.00 | 9,130.0000 | 169,500,000 | 9999.99% | 0.01% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 1370 | $0.00 | 10,006.0000 | 168,700,000 | 15.86% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 639 | $219.08 | 9,367.0000 | 168,700,000 | 6.39% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 647 | $0.00 | 10,014.0000 | 168,700,000 | 6.91% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 313 | $219.08 | 9,701.0000 | 168,700,000 | 3.13% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Performance Stock Unit | 1370 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | J | Restricted Stock Unit | 807 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 647 | $0.00 | 807.0000 | 168,700,000 | 44.50% | 0.00% |
| Feb. 9, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 1515 | $0.00 | 1,515.0000 | 168,700,000 | 50.00% | 0.00% |
| Feb. 9, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 445 | $240.98 | 8,636.0000 | 168,700,000 | 4.90% | 0.00% |
| Feb. 9, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 1515 | $0.00 | 9,081.0000 | 168,700,000 | 20.02% | 0.00% |
| Feb. 8, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 2043 | $0.00 | 8,187.0000 | 168,700,000 | 33.25% | 0.00% |
| Feb. 8, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 621 | $240.30 | 7,566.0000 | 168,700,000 | 7.59% | 0.00% |
| Feb. 7, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | A | Restricted Stock Unit | 5405 | $0.00 | 5,405.0000 | 168,700,000 | 9999.99% | 0.00% |
| Feb. 8, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 2043 | $0.00 | 4,087.0000 | 168,700,000 | 33.33% | 0.00% |
| Jan. 29, 2024 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | A | Performance Stock Unit | 1370 | $0.00 | 1,370.0000 | 168,700,000 | 9999.99% | 0.00% |
| June 30, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 504 | $0.00 | 6,388.0000 | 167,900,000 | 8.57% | 0.00% |
| June 30, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 244 | $284.85 | 6,144.0000 | 167,900,000 | 3.82% | 0.00% |
| June 30, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 504 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| Feb. 17, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 767 | $0.00 | 2,135.0000 | 167,900,000 | 26.43% | 0.00% |
| Feb. 17, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | J | Restricted Stock Unit | 681 | $0.00 | 1,454.0000 | 167,900,000 | 31.90% | 0.00% |
| Feb. 17, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 767 | $0.00 | 5,884.0000 | 167,900,000 | 14.99% | 0.00% |
| Feb. 17, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 371 | $278.38 | 5,117.0000 | 167,900,000 | 6.76% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | J | Restricted Stock Unit | 553 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 453 | $0.00 | 553.0000 | 167,900,000 | 45.03% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 1515 | $0.00 | 3,030.0000 | 167,900,000 | 33.33% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 642 | $286.30 | 5,488.0000 | 167,900,000 | 10.47% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 220 | $286.30 | 6,130.0000 | 167,900,000 | 3.46% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 453 | $0.00 | 6,350.0000 | 167,900,000 | 7.68% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 462 | $286.30 | 5,897.0000 | 167,900,000 | 7.27% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 1515 | $0.00 | 6,359.0000 | 167,900,000 | 31.28% | 0.00% |
| Feb. 8, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Global Product Strat. | A | Restricted Stock Unit | 6130 | $0.00 | 6,130.0000 | 167,900,000 | 9999.99% | 0.00% |
| Jan. 25, 2023 | BIOGEN INC. | $BIIB | Izzar Rachid | Head of Alzheimer's Disease | A | Common Stock | 1783 | $0.00 | 4,844.0000 | 167,900,000 | 58.25% | 0.00% |